Revvity's webinar on cellular RIPTAC assays : The New Frontier
🧬 The new frontier of PPI research is here!
Protein-protein interactions (PPIs) are fundamental to cellular function, but studying them in their native environment remains challenging.
Join Revvity for an upcoming webinar exploring how AlphaLISA™ SureFire® no-wash technology enables detection of endogenous PPIs and RIPTAC-induced ternary complexes in wild-type cells.
🔬 What you’ll learn:
• Detection of endogenous protein interactions without complex workflows
• AR/BRD4 and ER/BRD4 RIPTAC ternary-complex biology
• Myddosome assembly in native cellular systems
• Translational applications in PBMCs, whole blood, and tumor samples
• How these approaches can support next-generation drug discovery programs
🎙️ Featured Speaker: Antony Sheehan, PhD
Director of Immunoassays & Site Head, TGR BioSciences (an Abcam company)
📅 September 23
⏰ 10 AM ET | 4 PM CET
👉 Register now and discover how AlphaLISA™ SureFire® is advancing endogenous PPI and RIPTAC research.
#Revvity #AlphaLISA #SureFire #RIPTAC #PROTAC #ProteinProteinInteractions #DrugDiscovery #Oncology #Biotech #TargetedProteinDegradation
Powered By GrowthZone